Topic: EPIZYME
17 results were found.
Ipsen to acquire Epizyme for $247 million - June 27, 2022
Epizyme Q1 revenue increased 14% - May 11, 2022
Epizyme Q4 revenue $11.6 million - March 2, 2022
Epizyme Q2 collaboration revenue $5.9 million - August 9, 2019
Epizyme Q1 net loss $32.3 million - May 6, 2019
Epizyme appoints Shefali Agarwal as chief medical officer - July 24, 2018
Epizyme appoints Kevin Conroy to board - February 8, 2017
Epizyme Q2 net loss $28 million, R&D expenses $21.5 million - August 8, 2016
Epizyme Q1 net loss $22.9 million, will boost R&D - May 10, 2016
Epizyme appoints Susan Graf as chief business officer - April 26, 2016
Epizyme net loss $132.4 million, company reveals restructuring plan - March 9, 2016
Epizyme Q3 collaboration revenue $0.4 million - November 10, 2015
Epizyme appoints Robert Bazemore as president and CEO - August 7, 2015
Epizyme appoints Andrew Singer CFO - February 4, 2015
Epizyme names president of research - January 30, 2015
Epizyme elects Kenneth Bate to board of directors - December 15, 2014
Epizyme appoints Jason P. Rhodes president - July 4, 2013